Manhattan Scientifics, Inc. (MHTX)

Manhattan Scientifics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-1.17	-4.76	-3.67	4.31	-1.23
Depreciation & Amortization	0	0	0	0	0
Share-Based Compensation	0	0	0	0.02	0.37
Other Operating Activities	0.97	4.41	3.24	-4.73	0.54
Operating Cash Flow	-0.19	-0.35	-0.42	-0.39	-0.32
Capital Expenditures	0	0	0	-0	0
Acquisitions	0	0.3	0.3	0.3	0.3
Change in Investments	-0.1	-0.03	-	-0.48	-0.04
Other Investing Activities	0.2	0.06	-	0.67	0.08
Investing Cash Flow	0.1	0.33	0.3	0.48	0.34
Common Stock Issued	0	0	0	0.02	0.36
Other Financing Activities	-0.02	-0.04	-	-	-0.21
Financing Cash Flow	-0.02	-0.04	0	0.02	0.15
Net Cash Flow	-0.11	-0.06	-0.12	0.09	0.17
Free Cash Flow	-0.19	-0.35	-0.42	-0.39	-0.32
Free Cash Flow Margin	-	-698.00%	-842.00%	-784.00%	-325.77%
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.